KRAS and pancreatic adenocarcinoma: Mutations involving the Kirsten rat sarcoma viral oncogene homolog (KRAS) gene are present in the vast majority of pancreatic adenocarcinomas (more than 90%) and less frequently in pulmonary adenocarcinoma (15–30%) [3–6].